This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Mark Your Calendar for Next Year's Event!
May 9-12, 2022Hynes Convention Center, Boston

Matthias Kretschmer, PhD
Senior Director Analytical Sciences at Alnylam Pharmaceuticals


Senior Director of Analytical Sciences at Alnylam Pharmaceuticals, responsible since 2008 for development of analytical methods and testing of siRNA pharmaceuticals. Prior to Alnylam, lead the Product Quality Management and QC Chemistry groups at Biogen from 2002 – 2008. From 1997 to 2002 responsible for the development of release test methods for Tysabri. Before Biogen, Scientist in Product Biochemistry at AutoImmune, characterization of myelin
proteins. PhD in chemistry from University of Leipzig. Discovered yeast PFK2 / FBPase 2 genes during postdoctoral training in yeast genetics and enzymology at Harvard Med. School. Throughout career developed software for analytical and quality testing purposes.

Agenda Sessions

  • ROOM 205A: Impurity Strategy - Evaluating Consensus Impurity Lists